Filing Details

Accession Number:
0001033905-20-000085
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-06 08:17:46
Reporting Period:
2020-07-01
Accepted Time:
2020-07-06 08:17:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1033905 Luminex Corp LMNX Surgical & Medical Instruments & Apparatus (3841) 742747608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1105966 Ii Walter G Loewenbaum 12212 Technology Boulevard
Austin TX 78727
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-01 7,853 $32.88 801,562 No 4 S Indirect Spouse
Common Stock Disposition 2020-07-02 15,800 $32.86 785,762 No 4 S Indirect Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Spouse
No 4 S Indirect Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 550,189 Direct
Common Stock 96,614 Indirect Partnership
Common Stock 428,520 Indirect Trusts
Footnotes
  1. This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1, adopted by the seller on May 27,2020 for shares acquired as founder's stock prior to the IPO on March 30, 2000. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.85 to $32.925 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  3. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.85 to $32.90 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.